logo
episode-header-image
Apr 16
39m 25s

Isomorphic Labs Discusses AI-Driven Drug...

Nvidia
About this episode
Max Jaderberg and Sergei Yakneen from Isomorphic Labs discuss how AI is enhancing drug discovery by treating biology as an information processing system. They share how advanced AI models like AlphaFold 3 are accelerating the pipeline and paving the way for a future of precision medicine. 
Up next
Yesterday
How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264
Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies ... Show More
31m 40s
Jul 2
Alembic and the Future of AI in Marketing - Ep. 263
Tomás Puig, founder and CEO of Alembic, joins the NVIDIA AI Podcast to discuss the intersection of AI, data, and marketing. He shares how Alembic uses advanced mathematics and AI—particularly spiking neural networks and causal inference—to help brands extract actionable insights ... Show More
39m 44s
Jun 25
Hippocratic AI's Munjal Shah on How AI Agents Are Expanding Healthcare Capacity - Ep. 262
Munjal Shah, CEO of Hippocratic AI, discusses how AI agents can dramatically expand healthcare capacity and access. With 1.8 million patient calls completed and an 8.95/10 satisfaction rating, Hippocratic's safety-focused LLM demonstrates how optimized AI inference can handle rou ... Show More
21m 49s
Recommended Episodes
Mar 2025
How AI is saving billions of years of human research time | Max Jaderberg
Can AI compress the years long research time of a PhD into seconds? Research scientist Max Jaderberg explores how “AI analogs” simulate real-world lab work with staggering speed and scale, unlocking new insights on protein folding and drug discovery. Drawing on his experience wor ... Show More
19m 15s
Feb 2025
Understanding AI’s Expanding Role in Drug Discovery and Life Sciences R&D - Liran Belenzon of BenchSci
Today’s guest is Liran Belenzon, Co-founder and CEO of BenchSci. BenchSci is a global leader in AI solutions for preclinical R&D that helps decipher complex biomedical research using proprietary technology. Liran joins us to discuss how AI is transforming disease biology research ... Show More
19m 3s
Dec 2024
How AI is saving billions of years of human research time | Max Jaderberg
Can AI compress the yearslong research time of a PhD into seconds? Research scientist Max Jaderberg explores how “AI analogs” simulate real-world lab work with staggering speed and scale, unlocking new insights on protein folding and drug discovery. Drawing on his experience work ... Show More
18m 2s
Oct 2023
DeepMind’s Latest AlphaFold AI Model Revolutionizing Drug Discovery
In this episode, we delve into how DeepMind's newest iteration of the AlphaFold model is revolutionizing the field of drug discovery. Explore the breakthroughs and potential applications that this cutting-edge technology brings to the pharmaceutical world. Invest in AI Box: h ... Show More
6m 34s
May 2023
The AI Will See You Now: Exploring Biomedical AI and Google’s Med-PaLM2 With Karan Singhal
What if AI could revolutionize healthcare with advanced language learning models? Sarah and Elad welcome Karan Singhal, Staff Software Engineer at Google Research, who specializes in medical AI and the development of MedPaLM2. On this episode, Karan emphasizes the importance of s ... Show More
42m 48s
Oct 2024
Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology
"Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology" - In this episode, we dive deep into the revolutionary world of biotechnology and its transformative impact on pharmaceuticals. Discover how cutting-edge innovations are reshaping drug development, accelerating vac ... Show More
20m 43s
Apr 2024
How AI is Accelerating the Search for New Medicines
Why is the process of creating a new and highly beneficial pharmaceutical drug so difficult? What are the hurdles researchers face when trying to identify a new drug? Why are side effects so challenging to predict? Why are pharmaceutical drugs so expensive? In today's episode, we ... Show More
23m 25s
Feb 2025
Satya Nadella – Microsoft’s AGI Plan & Quantum Breakthrough
Satya Nadella on: Why he doesn’t believe in AGI but does believe in 10% economic growth; Microsoft’s new topological qubit breakthrough and gaming world models;Whether Office commoditizes LLMs or the other way around. Watch on Youtube; listen on Apple Podcasts or Spotify.-------- ... Show More
1h 16m
Nov 2024
The Future of AI: Predictions and Realities
In this episode, Jaeden Schafer discusses the current challenges and developments in the AI industry, particularly focusing on the limitations faced by major players like OpenAI and Anthropic. The conversation explores the anticipated improvements in AI models, the predictions fo ... Show More
18m 14s
May 2024
GSK’s Use of AI in Vaccine Tech, Drug Discovery
GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Techno ... Show More
42m 42s